Efficacy Study of Recombinant Interleukin-21 in the Treatment of Ovarian Cancer
Clinical trial NCT00523380 · COMPLETED
Trial details
- NCT number
- NCT00523380
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-04
- Primary completion
- 2009-01-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.